Literature DB >> 17959844

Estrogen effects on skeletal muscle insulin-like growth factor 1 and myostatin in ovariectomized rats.

Wan-Jung A Tsai1, Kathleen M McCormick, Daniel A Brazeau, Gayle A Brazeau.   

Abstract

Previous work showed that estrogen replacement attenuates muscle growth in immature rats. The present study examined muscle insulin-like growth factor-1 (IGF-1) and myostatin expression to determine whether these growth regulators might be involved in mediating estrogen's effects on muscle growth. IGF-1 and myostatin message and protein expression in selected skeletal muscles from 7-week-old sham-ovariectomized (SHAM) and ovariectomized rats that received continuous estrogen (OVX/E2) or solvent vehicle (OVX/CO) from an implant for 1 week or 5 weeks was measured. In the 1-week study, ovariectomy increased IGF-1 mRNA expression in fast extensor digitorum longus and gastrocnemius muscles; the increase was reversed by estrogen replacement. A similar trend was observed in the slow soleus muscle, although the change was not statistically significant. In contrast to mRNA, muscle IGF-1 protein expression was not different between SHAM and OVX/ CO animals in the 1-week study. One week of estrogen replacement significantly decreased IGF-1 protein level in all muscles examined. Myostatin mRNA expression was not different among the 1-week treatment groups. One week of estrogen replacement significantly increased myostatin protein in the slow soleus muscle but not the fast extensor digitorum longus and gastrocnemius muscles. There was no treatment effect on IGF-1 and myostatin expression in the 5-week study; this finding suggested a transient estrogen effect or upregulation of a compensatory mechanism to counteract the estrogen effect observed at the earlier time point. This investigation is the first to explore ovariectomy and estrogen effects on skeletal muscle IGF-1 and myostatin expression. Results suggest that reduced levels of muscle IGF-1 protein may mediate estrogen's effect on growth in immature, ovariectomized rats. Increased levels of muscle myostatin protein may also have a role in mediating estrogen's effects on growth in slow but not fast skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17959844     DOI: 10.3181/0704-RM-92

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  12 in total

1.  Estrogen replacement and skeletal muscle: mechanisms and population health.

Authors:  Peter M Tiidus; Dawn A Lowe; Marybeth Brown
Journal:  J Appl Physiol (1985)       Date:  2013-07-18

2.  Testosterone and progesterone, but not estradiol, stimulate muscle protein synthesis in postmenopausal women.

Authors:  Gordon I Smith; Jun Yoshino; Dominic N Reeds; David Bradley; Rachel E Burrows; Henry D Heisey; Anna C Moseley; Bettina Mittendorfer
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

3.  Diminished satellite cells and elevated adipogenic gene expression in muscle as caused by ovariectomy are averted by low-magnitude mechanical signals.

Authors:  Danielle M Frechette; Divya Krishnamoorthy; Benjamin J Adler; M Ete Chan; Clinton T Rubin
Journal:  J Appl Physiol (1985)       Date:  2015-04-30

4.  Expression of insulin-like growth factor 1 isoforms in the rabbit oculomotor system.

Authors:  Cheng-Yuan Feng; Christopher S von Bartheld
Journal:  Growth Horm IGF Res       Date:  2011-06-23       Impact factor: 2.372

5.  Increased body fat mass and tissue lipotoxicity associated with ovariectomy or high-fat diet differentially affects bone and skeletal muscle metabolism in rats.

Authors:  Camille Tagliaferri; Jérôme Salles; Jean-François Landrier; Christophe Giraudet; Véronique Patrac; Patrice Lebecque; Marie-Jeanne Davicco; Audrey Chanet; Corinne Pouyet; Amélie Dhaussy; Alain Huertas; Yves Boirie; Yohann Wittrant; Véronique Coxam; Stéphane Walrand
Journal:  Eur J Nutr       Date:  2014-11-05       Impact factor: 5.614

6.  17β-estradiol represses myogenic differentiation by increasing ubiquitin-specific peptidase 19 through estrogen receptor α.

Authors:  Masahiro Ogawa; Ryoichi Yamaji; Yasuki Higashimura; Naoki Harada; Hitoshi Ashida; Yoshihisa Nakano; Hiroshi Inui
Journal:  J Biol Chem       Date:  2011-10-04       Impact factor: 5.157

7.  Skeletal myopathy in a rat model of postmenopausal heart failure with preserved ejection fraction.

Authors:  Rachel C Kelley; Lauren Betancourt; Andrea M Noriega; Suzanne C Brinson; Nuria Curbelo-Bermudez; Dongwoo Hahn; Ravi A Kumar; Eliza Balazic; Derek R Muscato; Terence E Ryan; Robbert J van der Pijl; Shengyi Shen; Coen A C Ottenheijm; Leonardo F Ferreira
Journal:  J Appl Physiol (1985)       Date:  2021-11-18

Review 8.  Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease.

Authors:  Keith Richard Mitchelson; Wen-Yan Qin
Journal:  World J Biol Chem       Date:  2015-08-26

Review 9.  Sexual dimorphism in skeletal muscle protein turnover.

Authors:  Gordon I Smith; Bettina Mittendorfer
Journal:  J Appl Physiol (1985)       Date:  2015-12-23

Review 10.  Vascular dysfunction as a potential culprit of sarcopenia.

Authors:  Yun Kyung Jeon; Myung Jun Shin; Sunil Kumar Saini; Carlo Custodero; Monica Aggarwal; Stephen D Anton; Christiaan Leeuwenburgh; Robert T Mankowski
Journal:  Exp Gerontol       Date:  2020-12-26       Impact factor: 4.032

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.